168 related articles for article (PubMed ID: 33543331)
1. Clinical characteristics and prognostic factors of stage IC ovarian clear cell carcinoma: a Surveillance, Epidemiology, and End Results (SEER) analysis.
Chen Q; Wang S; Lang JH
Arch Gynecol Obstet; 2021 Aug; 304(2):521-529. PubMed ID: 33543331
[TBL] [Abstract][Full Text] [Related]
2. Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
Nasioudis D; Chapman-Davis E; Frey MK; Witkin SS; Holcomb K
J Gynecol Oncol; 2017 Nov; 28(6):e71. PubMed ID: 28758377
[TBL] [Abstract][Full Text] [Related]
3. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
[TBL] [Abstract][Full Text] [Related]
4. Oncologic outcomes of fertility-sparing surgery in early stage epithelial ovarian cancer: a population-based propensity score-matched analysis.
Xie Q; Meng X; Liao Q
Arch Gynecol Obstet; 2022 Nov; 306(5):1679-1688. PubMed ID: 35364698
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.
Oseledchyk A; Leitao MM; Konner J; O'Cearbhaill RE; Zamarin D; Sonoda Y; Gardner GJ; Long Roche K; Aghajanian CA; Grisham RN; Brown CL; Snyder A; Chi DS; Soslow RA; Abu-Rustum NR; Zivanovic O
Ann Oncol; 2017 Dec; 28(12):2985-2993. PubMed ID: 28950307
[TBL] [Abstract][Full Text] [Related]
6. Safety of fertility-sparing surgery in young women with stage I endometrioid epithelial and mucinous ovarian cancer: A population-based analysis.
Li J; Qiao H; Liu Y; Huang C; Cheng A; Lin Z; Wang L; Lu H
Eur J Surg Oncol; 2024 Jan; 50(1):107276. PubMed ID: 38064863
[TBL] [Abstract][Full Text] [Related]
7. Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study.
Liu T; Gao Y; Li S; Xu S
J Ovarian Res; 2024 Jun; 17(1):119. PubMed ID: 38824600
[TBL] [Abstract][Full Text] [Related]
8. Outcomes after fertility-sparing surgery of early-stage ovarian cancer: A nationwide population-based study.
Lee CY; Chiang CJ; Tai YJ; Hsu HC; Chen YL; Chiang YC; Wu CY; Lee WC; Hwa HL; Cheng WF
Cancer Med; 2024 Apr; 13(7):e7132. PubMed ID: 38606892
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
Yang ZJ; Wei RJ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma.
Chen Q; Wang S; Lang JH
J Ovarian Res; 2020 Oct; 13(1):123. PubMed ID: 33069259
[TBL] [Abstract][Full Text] [Related]
11. A Swedish Nationwide prospective study of oncological and reproductive outcome following fertility-sparing surgery for treatment of early stage epithelial ovarian cancer in young women.
Johansen G; Dahm-Kähler P; Staf C; Flöter Rådestad A; Rodriguez-Wallberg KA
BMC Cancer; 2020 Oct; 20(1):1009. PubMed ID: 33076846
[TBL] [Abstract][Full Text] [Related]
12. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
Wang J; Li J; Chen R; Lu X
Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study.
Zhu C; Zhu J; Qian L; Liu H; Shen Z; Wu D; Zhao W; Xiao W; Zhou Y
BMC Cancer; 2021 Mar; 21(1):322. PubMed ID: 33766002
[TBL] [Abstract][Full Text] [Related]
14. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract][Full Text] [Related]
15. Evolving population-based statistics for rare epithelial ovarian cancers.
Matsuo K; Machida H; Matsuzaki S; Grubbs BH; Klar M; Roman LD; Sood AK; Gershenson DM; Wright JD
Gynecol Oncol; 2020 Apr; 157(1):3-11. PubMed ID: 31954534
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.
Zhou J; He ZY; Li FY; Sun JY; Lin HX; Wu SG; Chen QH
Oncotarget; 2016 Feb; 7(7):7952-9. PubMed ID: 26788911
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
18. Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries.
Crafton SM; Cohn DE; Llamocca EN; Louden E; Rhoades J; Felix AS
Cancer; 2020 Mar; 126(6):1217-1224. PubMed ID: 31774553
[TBL] [Abstract][Full Text] [Related]
19. Women With Ovarian Cancer and With Fertility Preservation: A Survival Analysis Using the Surveillance, Epidemiology, and End Results Database and Construction of Nomograms to Predict Cancer-Specific Survival.
Hou YM; Yu H; Hao JT; Feng F; An RF
Front Oncol; 2022; 12():860046. PubMed ID: 35480098
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety of fertility sparing surgery in early stage ovarian cancer: comparison to standard radical surgical procedures.
Ditto A; Martinelli F; Bogani G; Lorusso D; Carcangiu M; Chiappa V; Reato C; Donfrancesco C; De Carrillo KJ; Raspagliesi F
Gynecol Oncol; 2015 Jul; 138(1):78-82. PubMed ID: 25969349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]